LS
LSBWF
LakeShore Biopharma Co., Ltd.
No data for this timeframe.
Vol
SEC Reports2
Recent Activity
May 28, 2026
SEC
LakeShore Biopharma has called an Extraordinary General Meeting (EGM) for June 19, 2026, to vote on a previously announc
6-K — Impact 7/10
Apr 29, 2026
SEC
LakeShore Biopharma amended its going-private merger agreement, slashing the per-share consideration from $0.90 to $0.06
6-K — Impact 8/10
Latest Reports
BULLISH
6-K
7/10
LakeShore Biopharma has called an Extraordinary General Meeting (EGM) for June 19, 2026, to vote on a previously announc
May 28, 2026
BEARISH
6-K
8/10
LakeShore Biopharma amended its going-private merger agreement, slashing the per-share consideration from $0.90 to $0.06
Apr 29, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 7.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.